Wird geladen...
NT-36 FOCUSED ULTRASOUND ENHANCED CHEMOTHERAPEUTIC AGENT (TEMOZOLOMIDE) DELIVERY FOR BRAIN TUMOR TREATMENT: A PRECLINICAL INVESTIGATION
Malignant brain tumor is highly aggressive disease with high recurrence and motility rate. Current therapeutic approaches including surgery, radiation and chemotherapy only provide limited disease progression control. One of the major issues results its poor outcome is the blockade of chemotherapeut...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218445/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou265.34 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|